WallStreetZenWallStreetZen

NASDAQ: SYRE
Spyre Therapeutics Inc Stock Ownership - Who owns Spyre Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Spyre Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Heidy KingjonesCLO;Sec2026-10-01400$89.24
$35.70kSell
Scott L. BurrowsCFO2026-10-01229$93.57
$21.43kSell
Scott L. BurrowsCFO2026-10-013,071$92.95
$285.45kSell
Scott L. BurrowsCFO2026-10-012,100$91.92
$193.03kSell
Scott L. BurrowsCFO2026-10-011,500$90.27
$135.41kSell
Cameron TurtleCEO2026-10-014,990$93.37
$465.92kSell
Cameron TurtleCEO2026-10-013,989$92.31
$368.22kSell
Cameron TurtleCEO2026-10-012,638$91.49
$241.35kSell
Cameron TurtleCEO2026-10-012,683$90.10
$241.74kSell
Cameron TurtleCEO2026-10-01600$89.14
$53.48kSell

1 of 12

SYRE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SYRE insiders and whales buy or sell their stock.

SYRE Shareholders

What type of owners hold Spyre Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fairmount Funds Management LLC10.83%10,283,659$1.07BInsider
Baker Bros Advisors LP3.26%3,094,590$321.40MInsider
Orbimed Advisors LLC2.98%2,829,748$293.90MInsider
Novartis Bioventures Ltd2.29%2,175,314$225.93MInsider
Anthony G. Quinn1.08%1,025,680$106.53MInsider
Cameron Turtle0.57%537,540$55.83MInsider
George Georgiou0.47%446,337$46.36MInsider
David George Lowe0.22%212,040$22.02MInsider
Armen Shanafelt0.22%207,619$21.56MInsider
Jonathan Alspaugh0.17%165,372$17.18MInsider

1 of 3

SYRE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SYRE0.10%22.70%Net SellingNet Selling
PCVX0.11%12.80%Net SellingNet Selling
MDGL0.03%99.97%Net BuyingNet Buying
TGTX0.07%48.64%Net SellingNet Selling
IBRX0.02%7.21%Net BuyingNet Selling
View Top Biotech Stocks

Spyre Therapeutics Stock Ownership FAQ

Who owns Spyre Therapeutics?

Spyre Therapeutics (NASDAQ: SYRE) is owned by 0.10% institutional shareholders, 22.70% Spyre Therapeutics insiders, and 77.20% retail investors. Fairmount Funds Management LLC is the largest individual Spyre Therapeutics shareholder, owning 10.28M shares representing 10.83% of the company. Fairmount Funds Management LLC's Spyre Therapeutics shares are currently valued at $1.07B.

If you're new to stock investing, here's how to buy Spyre Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.